Faculty Digital Archive

Archive@NYU >
Stern School of Business >
Finance Working Papers >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2451/31543

Title: Glucksman Fellowship Program Student Research Reports
Authors: Welt, Samuel
Shortt, Karen
Livne, Oren
Orenstein, Ismael
Silber, William L., Editor
Issue Date: 30-Apr-2012
Series/Report no.: FIN-12-004
Abstract: The Glucksman Institute for Research in Securities Markets awards fellowships each year to outstanding second year Stern MBA students to work on independent research projects under a faculty member's supervision. Four research projects completed by the Glucksman Fellows of 2011-2012 are included in this special issue of the Finance Department Working Paper Series. These papers focus on important topics in empirical financial economics. Samuel Welt, under the supervision of William Silber, analyzes the economic and political factors that determine the magnitude of increases in the debt ceiling voted by Congress. Karen Shortt, under the direction of Aswath Damodaran , investigates the relationship between corporate environmental performance and abnormal stock price movements of a firm. Oren Livne, under the supervision of Alexander Ljungqvist, provides an overview of the evolution of the private company secondary marketplace in the United States, and evaluates the ability of secondary market data to predict share price changes post IPO. Ismael Orenstein, under the supervision of Yakov Amihud, analyzes the impact of the Federal Reserve’s Quantitative Easing (QE) program on the relative pricing of treasury securities. These papers, reflecting the research effort of four outstanding Stern MBA students, are summarized in more detail in the Table of Contents on the next page.
URI: http://hdl.handle.net/2451/31543
Appears in Collections:Finance Working Papers

Files in This Item:

File Description SizeFormat
WP fin dept 2012-1.pdfMain Working Paper2.74 MBAdobe PDFView/Open

Items in Faculty Digital Archive are protected by copyright, with all rights reserved, unless otherwise indicated.


The contents of the FDA may be subject to copyright, be offered under a Creative Commons license, or be in the public domain.
Please check items for rights statements. For information about NYU’s copyright policy, see http://www.nyu.edu/footer/copyright-and-fair-use.html 
Valid XHTML 1.0 | CSS